Our mission is to reduce the harm caused by benzodiazepines and Z-drugs by making evidence-based improvements to the prescribing of these medications.
Reported officers (all unpaid)
No paid executives reported in 2024. The Alliance for Benzodiazepine Best Practices reported 9 unpaid officers and board members on its 990.
Top pay as a share of expenses
In 2023, the highest total compensation at The Alliance for Benzodiazepine Best Practices equaled 31% of the organization's total expenses. The median for medical research organizations is 9%.
Based on 1,042 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.
Revenue and expenses over time
The Alliance for Benzodiazepine Best Practices reported revenue and expenses across 2 filing years.
What Medical Research executives earn
The Alliance for Benzodiazepine Best Practices reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $120,264.
These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).
See full Medical Research compensation data →Similar Organizations
Eugene, OR
Cottage Grove, OR
Wilsonville, OR
Salem, OR
Common questions about The Alliance for Benzodiazepine Best Practices
What are The Alliance for Benzodiazepine Best Practices's revenue and expenses?
In 2024, The Alliance for Benzodiazepine Best Practices reported $133k in total revenue and $94k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.